SUBJECTS WITH RESECTABLE AND LOCALIZED GASTRIC CANCER

Clinical trials for SUBJECTS WITH RESECTABLE AND LOCALIZED GASTRIC CANCER explained in plain language.

Never miss a new study

Get alerted when new SUBJECTS WITH RESECTABLE AND LOCALIZED GASTRIC CANCER trials appear

Sign up with your email to follow new studies for SUBJECTS WITH RESECTABLE AND LOCALIZED GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug aims to shrink GI cancers before surgery

Disease control Ongoing

This phase 2 trial tests whether giving the immune checkpoint inhibitor IMC-001 before surgery can shrink tumors in people with resectable gastric, esophageal, or liver cancer. About 48 participants will receive two cycles of the drug, then undergo surgery. The main goal is to se…

Matched conditions: SUBJECTS WITH RESECTABLE AND LOCALIZED GASTRIC CANCER

Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

SUBJECTS WITH RESECTABLE AND LOCALIZED GASTRIC CANCER

Get alerted when new SUBJECTS WITH RESECTABLE AND LOCALIZED GASTRIC CANCER trials appear

New drug aims to shrink GI cancers before surgery